Skip to content

Clinical trials

Completed Lipid Metabolism Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Status: Completed Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20081
20131
20141
20161
20173
20181
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akcea Therapeutics2
Kastle Therapeutics, LLC2
Université de Sherbrooke2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Eli Lilly and Company1
NewAmsterdam Pharma1
Pfizer1
Sumitomo Pharma Switzerland GmbH1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders15
Metabolic Diseases11
Dyslipidemias8
Hyperlipidemias7
Genetic Diseases, Inborn6
Hyperlipoproteinemias6
Lipid Metabolism, Inborn Errors5
Metabolism, Inborn Errors5
Hypercholesterolemia4
Infant, Newborn, Diseases4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.